Hermetica Superfood Encyclopedia
The Short Answer
Cypripedium parviflorum contains phenanthrenequinones—most notably cypripedine—alongside potassium oxalate, volatile terpenes such as linalool and alpha-farnesene, and stilbenoid phenolics that are hypothesized to underlie the plant's traditional nervine and antispasmodic activity through mechanisms extrapolated from related orchid species. Its primary historical application as an Appalachian nerve tonic for anxiety, pain, and spasm rests entirely on ethnobotanical record and genus-level phytochemistry, with no controlled clinical trials or quantified human efficacy data available to date.
CategoryHerb
GroupEuropean
Evidence LevelPreliminary
Primary Keywordlady's slipper herb benefits
Lady's Slipper — botanical close-up
Health Benefits
**Nervine and Sedative Activity**
Traditional Appalachian and Native American herbalists used rhizome preparations as a central nervous system calming agent for anxiety, insomnia, and nervous exhaustion; the biological basis is unconfirmed but attributed speculatively to phenanthrenequinone constituents such as cypripedine acting on neural pathways similar to those modulated by related plant phenolics.
**Antispasmodic Effects**
Decoctions of the root were historically prescribed for muscle spasm, epileptic-type convulsions, and uterine cramping during childbirth; the mechanism remains uncharacterized at the molecular level, though antispasmodic properties of phenolic quinones in related orchid genera provide a working hypothesis.
**Analgesic Properties**
Both European-trained herbalists and Indigenous practitioners employed lady's slipper preparations as an anodyne for headache, neuralgia, toothache, and rheumatic pain; no quantified analgesic potency data exist for C. parviflorum specifically.
**Anti-inflammatory Potential**
Genus-level Cypripedium research identifies phenanthraquinones (cypritibetquinones A and B) with putative anti-inflammatory activity inferred from structural analogy to other phenanthrenoid anti-inflammatories; no in vitro or in vivo inflammation models have been applied directly to C. parviflorum extracts.
**Diaphoretic and Febrifuge Use**
Traditional preparations were used to promote sweating and reduce fever in acute illness; this property, common across many tonic herbs, has not been mechanistically studied in this species.
**Diuretic Action**
Chinese ethnomedicine records use of Cypripedium stems and rhizomes for edema and gonorrhea-related urinary complaints, consistent with a mild diuretic effect; the potassium oxalate content may paradoxically complicate renal use by increasing urinary oxalate load.
**Chemopreventive Hypothesis**
Related orchid phenanthrenes have demonstrated apoptosis induction in cancer cell lines at IC50 values around 5.0 µM in preliminary in vitro screens; this finding cannot be directly attributed to C. parviflorum without species-specific phytochemical and bioassay confirmation.
Origin & History
Natural habitat
Cypripedium parviflorum, the yellow lady's slipper orchid, is native to North America, ranging from the eastern United States through Appalachia and northward into Canada, with populations also documented across temperate Asia. It grows in rich, moist woodlands, calcareous fens, and forest margins, preferring partial shade and well-drained alkaline soils with significant organic matter. The species has never been systematically cultivated for medicinal purposes; wild harvesting for traditional Appalachian and Native American herbal medicine contributed substantially to its current rarity, prompting conservation protections across multiple U.S. states.
“Cypripedium parviflorum holds a prominent place in North American ethnobotanical history, documented among numerous Indigenous nations—including the Ojibwe, Cherokee, Iroquois, and Menominee—who used the rhizome as a nerve-calming remedy, antispasmodic, and analgesic, particularly for managing pain during childbirth, headaches, and nervous disorders exacerbated by trauma or emotional distress. European settlers in Appalachia integrated lady's slipper into the regional herbal tradition as a substitute for valerian (Valeriana officinalis), earning it folk names such as 'American valerian' and 'nervroot,' and it appeared in official U.S. pharmacopoeias and dispensatories during the 19th century as a recognized nervine and antispasmodic. In Chinese traditional medicine, Cypripedium species were used for edema, dysentery, gastritis, bone fractures, and gonorrhea, reflecting a broader tonic and anti-infective role distinct from the North American nervine emphasis. Intense commercial harvesting in the late 19th and early 20th centuries to supply the herbal medicine trade drove wild populations to rarity, ultimately leading to federal and state protections that effectively removed the plant from the commercial ingredient supply.”Traditional Medicine
Scientific Research
The evidentiary base for Cypripedium parviflorum as a medicinal agent is extremely limited and confined almost entirely to ethnobotanical documentation and genus-level phytochemical characterization; no clinical trials, randomized controlled studies, or formal pharmacological investigations targeting this species have been published in indexed medical or botanical literature. Phytochemical studies of the broader Cypripedium genus have identified and partially characterized cypripedine, cypritibetquinones A and B, and cypripediquinone A, providing a chemical scaffold for future bioactivity research but offering no dose-response, bioavailability, or safety data applicable to human supplementation. In vitro assays conducted on related orchid phenanthrenes—not C. parviflorum—have reported apoptotic activity in cancer cell lines (IC50 ~5.0 µM), representing preclinical hypothesis generation rather than translatable clinical evidence. Researchers and consumers should treat all purported therapeutic effects of this species as unvalidated traditional claims pending dedicated pharmacological and clinical investigation.
Preparation & Dosage
Traditional preparation
**Traditional Rhizome Decoction**
Dried rhizome boiled in water for 15–20 minutes; historical Appalachian doses used approximately 1–2 teaspoons of dried root per cup of water, consumed 1–3 times daily for nervous complaints—no validated therapeutic dose established.
**Tincture (Hydroethanolic Extract)**
1–4 mL up to three times daily, though no standardization percentage or active marker has been established for C
Historical preparations used a 1:5 ratio in 40–60% ethanol; folk doses ranged from . parviflorum specifically.
**Powdered Root in Capsule Form**
300–500 mg per capsule; this form is now exceedingly rare due to the plant's conservation status and legal protections in many jurisdictions
Occasionally offered in historical herbal commerce at .
**Paste or Poultice**
Crushed fresh rhizome applied topically for localized pain or rheumatism in traditional practice; glandular hair irritants in related species (C. reginae) suggest caution with dermal application.
**Conservation Note**
Wildcrafting Cypripedium parviflorum is illegal or heavily restricted across much of its native range; commercial preparations are virtually unavailable, and no cultivated-source standardized extract exists on the current supplement market.
Nutritional Profile
Cypripedium parviflorum has not been subjected to comprehensive proximate or micronutrient analysis; no macronutrient composition data (protein, fat, carbohydrate content) are available for any plant part from indexed nutritional databases. The most toxicologically significant constituent from a nutritional standpoint is potassium oxalate, present in quantities described as 'large' in genus-level phytochemical surveys, which acts as an antinutrient by binding dietary calcium and potentially increasing renal oxalate burden upon ingestion. Phenanthrenequinones including cypripedine and cypritibetquinones A and B, along with stilbenoid phenolics, represent the primary phytochemical categories of interest, though species-specific concentrations have not been quantified. Volatile aromatic compounds—alpha-farnesene, nerol, linalool, and various benzenoid acetates—are present in floral tissues primarily serving pollination ecology functions, with no nutritional significance established; bioavailability of any constituent from oral preparations is entirely undocumented.
How It Works
Mechanism of Action
No molecular mechanism has been directly characterized for Cypripedium parviflorum or its isolated constituents in peer-reviewed pharmacological studies. At the genus level, phenanthrenequinones such as cypripedine are structurally related to bioactive phenanthrenes found in other medicinal orchids (e.g., Dendrobium spp.), where mechanisms include intercalation with DNA, inhibition of topoisomerase activity, and induction of mitochondrial apoptosis pathways in cancer cell lines with IC50 values near 5.0 µM. Potassium oxalate, present in substantial quantities across Cypripedium species, functions as a calcium-binding agent that can disrupt calcium-dependent cellular signaling, which may partly explain both the irritant properties of the plant and speculative smooth-muscle relaxant effects. The volatile terpenes linalool and nerol, identified in floral fractions, are known in other botanical contexts to modulate GABA-A receptor activity and reduce neuronal excitability, offering a provisional mechanistic rationale for the traditional nervine classification, though this has not been validated in C. parviflorum.
Clinical Evidence
There are no published clinical trials evaluating Cypripedium parviflorum for any therapeutic indication; the complete absence of controlled human studies means that no outcomes have been formally measured, no effect sizes exist, and confidence in any specific clinical benefit is negligible by evidence-based medicine standards. Traditional use reports from Appalachian herbal practice and Native American ethnobotany document applications for anxiety, pain, spasm, and insomnia over centuries, but these constitute observational, retrospective ethnographic records rather than prospective clinical data. Genus-level preclinical findings—primarily in vitro phenanthrene bioactivity—have not been translated into human studies for any Cypripedium species, making extrapolation to C. parviflorum doubly speculative. Until species-specific pharmacological, toxicological, and clinical research is conducted, no evidence-based dosing recommendations or therapeutic claims can be substantiated.
Safety & Interactions
The safety profile of Cypripedium parviflorum is inadequately characterized in the scientific literature, with risk inferences drawn primarily from related species; the high potassium oxalate content of Cypripedium species presents a credible risk of oxalate-mediated toxicity including kidney stone formation, hypocalcemia-related symptoms, and mucosal irritation upon ingestion of significant quantities. Contact dermatitis and skin irritation are documented for the closely related C. reginae, which bears coarse glandular hairs containing phenolic irritants; while C. parviflorum's dermal risk profile is not formally quantified, caution with topical application and handling is warranted. No specific drug interaction studies exist, but the theoretical potential for additive central nervous system depression when combined with benzodiazepines, opioids, or sedative-hypnotics should be considered given the plant's traditional nervine classification and the GABA-modulating activity of constituent terpenes like linalool in other botanical models. Pregnancy and lactation safety is completely undocumented; the plant's historical use as a uterotonic adjunct during childbirth, combined with absent toxicological data, represents an absolute contraindication to use during pregnancy until safety data are established.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Cypripedium parviflorumYellow Lady's SlipperAmerican ValerianNervrootMoccasin FlowerCypripedium calceolus var. parviflorum
Frequently Asked Questions
What is lady's slipper used for in traditional medicine?
Lady's slipper (Cypripedium parviflorum) was traditionally used by Appalachian herbalists and numerous Indigenous North American nations as a nervine, antispasmodic, and analgesic for conditions including anxiety, insomnia, headaches, neuralgia, muscle spasm, and pain management during childbirth. In Chinese traditional medicine, related Cypripedium species were used for edema, dysentery, and gastritis. All of these uses are based on historical ethnobotanical record rather than validated clinical evidence.
Is lady's slipper orchid safe to take as a supplement?
The safety of Cypripedium parviflorum as a supplement has not been formally evaluated in clinical or toxicological studies. The plant contains significant amounts of potassium oxalate, which poses risks including kidney stone formation and mucosal irritation, and contact with related species has caused skin irritation. Additionally, wildcraft harvesting of this orchid is legally restricted or prohibited across much of its range, making commercial preparations both rare and of unverified composition.
What are the active compounds in lady's slipper root?
Phytochemical analyses of Cypripedium species identify phenanthrenequinones—most notably cypripedine and cypritibetquinones A and B—alongside cypripediquinone A, stilbenoid phenolics, and potassium oxalate as principal constituents. Floral tissues also contain volatile terpenes including linalool, nerol, and alpha-farnesene, though these serve pollination ecology functions. Species-specific concentrations for C. parviflorum have not been quantified in published scientific literature.
Why is lady's slipper orchid rare and can I buy it?
Cypripedium parviflorum became rare primarily due to intensive wild harvesting for the 19th- and early 20th-century herbal medicine trade, combined with habitat loss from land development and its naturally slow reproductive cycle as a terrestrial orchid. The species is now legally protected in many U.S. states and Canadian provinces, making wildcrafting illegal or heavily restricted. Commercially available standardized extracts or supplements derived from authenticated C. parviflorum are virtually nonexistent in the current market.
Are there any clinical trials supporting lady's slipper for anxiety or sleep?
No clinical trials have been conducted on Cypripedium parviflorum for anxiety, insomnia, or any other indication as of current available evidence. Its reputation as a nerve tonic rests entirely on centuries of ethnobotanical use in Appalachian and Indigenous North American herbal traditions, not on controlled human studies. Genus-level preclinical research on phenanthrenequinone constituents in other orchid species exists but cannot be directly applied to C. parviflorum without species-specific investigation.
What is the difference between lady's slipper rhizome and aerial parts for supplement use?
Lady's slipper supplements are primarily derived from the rhizome (underground stem), which contains the highest concentration of traditionally active compounds including phenanthrenequinones like cypripedine. Aerial parts (leaves and flowers) are sometimes used in herbal preparations but are considered less potent and less commonly available commercially. Historical herbalists specifically harvested and dried the rhizome for maximum nervine effects, making it the preferred form for traditional preparations.
How does lady's slipper compare to other nervine herbs like passionflower or valerian root?
Lady's slipper, passionflower, and valerian root are all traditional nervine herbs used for anxiety and sleep support, but differ in their phytochemistry and historical use patterns. Lady's slipper is less researched clinically than valerian and contains unique phenanthrenequinone alkaloids, while passionflower contains flavonoids and different alkaloid classes. Lady's slipper has stronger historical roots in Appalachian and Native American herbalism, whereas valerian has more European traditional use and scientific validation, making the choice between them dependent on individual preference and availability.
Who should avoid lady's slipper supplementation, and are there specific populations at higher risk?
Pregnant and nursing women should avoid lady's slipper due to insufficient safety data, and children's use is not well-established. Individuals taking sedative medications, anti-anxiety pharmaceuticals, or CNS depressants should consult a healthcare provider before use, as the herb may potentiate these effects. Those with allergies to orchids or a history of allergic reactions to plants in the Orchidaceae family should exercise caution with this ingredient.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w ladys-slipper-cypripedium-parviflorum curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
